The rebound of invasive meningococcal disease cases in France since the fall of 2022 was accompanied by an increase in adult epiglottitis. These cases were provoked mainly by isolates of serogroup W belonging to the clonal complex 11 of Neisseria meningitidis. Awareness and surveillance should be reinforced.

Article Link

Year:

2023

Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis

Article Link

Year:

2023

Changing patterns of invasive meningococcal disease and future immunization strategies

Article Link

Year:

2023

The rapid rebound of invasive meningococcal disease in France at the end of 2022

Article Link

Year:

2023

Haemophilus influenzae drug resistance in France from 2017 to 2021: consideration for treatment of otitis media

Article Link

Year:

2022

Correlates of protection for meningococcal surface protein vaccines: lessons from the past

Article Link

Year:

2022

Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease

Article Link

Year:

2022

Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic

Article Link

Year:

2022

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations

Article Link

Year:

2022

Implementation of a prospective study for enhancing surveillance of invasive bacterial infections in North Africa

Article Link

Year:

2022

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

Article Link

Year:

2022

Product review on the IMD serogroup B vaccine Bexsero®

Article Link

Year:

2022

Collaborators (3)

RAFIK BEKKAT-BERKANI

GlaxoSmithKline

UNITED STATES

Terry Nolan

University of Melbourne

AUSTRALIA

Ala-Eddine DEGHMANE

Assistant Professor

Institut Pasteur

FRANCE

Muhamed-Kheir Taha

Research Interests

Explore related searches

Contact this professor

Articles (19)

4CMenB journey to the 10-year anniversary and beyond

A Hunt for the Resistance of Haemophilus influnezae to Beta-Lactams

Biofilm Formation by Nontypeable Haemophilus Influenzae and Resistance to Complement-Mediated Clearance

Invasive meningococcal disease in older adults: current perspectives and call for action

The Bacterial Meningitis Epidemic in Banalia in the Democratic Republic of Congo in 2021

Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France

Characterizing Neisseria meningitidis in Southern Vietnam between 2012 and 2021: A predominance of the chloramphenicol-resistant ST-1576 lineage

Not Only Meningitis but Also Epiglottitis: An Emerging Clinical Presentation of Invasive Meningococcal Disease

Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis

Changing patterns of invasive meningococcal disease and future immunization strategies

The rapid rebound of invasive meningococcal disease in France at the end of 2022

Haemophilus influenzae drug resistance in France from 2017 to 2021: consideration for treatment of otitis media

Correlates of protection for meningococcal surface protein vaccines: lessons from the past

Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease

Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations

Implementation of a prospective study for enhancing surveillance of invasive bacterial infections in North Africa

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

Product review on the IMD serogroup B vaccine Bexsero®

Collaborators (3)

RAFIK BEKKAT-BERKANI

Terry Nolan

Ala-Eddine DEGHMANE

How do I reach out?

Meet Kite AI